List of molecules – clinical phase conducted in mtr

LIST OF MOLECULES HANDLED AT MTR
(CLINICAL)
_______________________________________________________________________
MICRO THERAPEUTIC RESEARCH LABS PRIVATE LIMITED
No.6, Kamarajar Salai, Selaiyur, East Tambaram,
Chennai – 600 059, Tamil Nadu, India.
This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 1 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Artemether+ Lumefantrine 40/240 mg tablet This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 2 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 3 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Drospirenone & Ethinyl 3/ 0.020 mg tablets, 3.0 This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 4 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Estradiol Valerate and 2 mg / 3 mg tablets, 2 mg/2 Carbonate and Magnesium 10/ 800/165mg Chewable Gestodene and Ethinyl 0.075/ 0.03 mg tablet, 0.06 mg This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 5 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Ibuprofen and Famotidine 800 mg & 26.6 mg Tablets Lamivudine + Zidovudine 150 mg / 300 mg tablets This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 6 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 7 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Norethindrone and Ethinyl mg, 1 mg / 0.035 mg, 1 mg/10 Olanzapine and Fluoxetine 6 mg /50 mg capsules Perindropil + Indapamide 5 / 1.25 mg tablets This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 8 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 9 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Tamsulosin Hydrochloride 0.4mg PR tablet This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 10 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Abacavir and Lamivudine 120/60 mg dispersible tablets, Potassium, Metronidazole 140 mg/125 mg /125 mg This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 11 of 12
NAME OF THE
STRENGTH AND DOSAGE
MOLECULE
ADMINISTRATION
Esomeprazole Magnesium DR Oral suspension 40 mg Progesterone and Estradiol 200 mg capsules Ezetimibe and Simvastatin 10 mg / 40 mg tablets Pyridoxine hydrochloride DR tablets10 mg/10 mg Amlodipine and Valsartan 10 mg/160 mg tablets This document contains confidential information and is the property of MTR.
Do not copy, disclose or circulate without authorization.
Page 12 of 12

Source: http://sixthstartech.co.in/mtr/List%20of%20Molecules%20Handled.pdf

Microsoft word - 4-tong.doc

Scientific Inquiry, vol. 9, No. 2, December, 2008, pp. 123 – 130 IIGSS Academic Publisher LOGISTIC MODEL BASED ON TWO-STAGE FCM CLUSTER AND ITS APPLICATIONS IN CURATIVE EFFECT ANALYSIS SHAN ZENGa, XIAOJUN TONGa,b*, QIUMING HUANGa aDepartment of Mathematics and Physics, Wuhan Polytechnic University, Wuhan 430023; bDepartment of Control Science and Engineering, Huazhong

Microsoft word - differentiating instruction for advanced learners-tomlinson

Differentiating Instruction For Advanced Learners In the Mixed-Ability Middle School Classroom By Carol Ann Tomlinson ERIC EC Digest #E536, October 1995 A particular challenge for middle school teachers is being able to differentiate or adapt instruction to respond to the diverse student needs found in inclusive, mixed-ability classrooms. This digest provides an overview of some k

© 2010-2017 Pdf Pills Composition